Sohrab Ahmadivand

Dr
Sohrab
Ahmadivand

Researcher
Faculty of Veterinary Medicine, Ludwig-Maximilians-University Munich, Germany
Email 
Sohrab.Ahmadivand [at] lmu.de
Biography
Ph.D. in Veterinary Science, with more than 10 years of academic, clinical and industrial experience in the field, focusing on viral pathogens and immunology, in particular development of effective Vaccines. Management and active role in more than 5 research and industrial vaccine projects using various types of inactivated, DNA and subunit vaccines against bacterial and viral pathogens. Having direct role in two national and international molecular epidemiology studies with first reports from Iran on five different DNA and RNA viruses, most of which are on the WOAH list. Vaccine project manager for 2 years. Guest Editor of Vaccines (MDPI), and member of International society for vaccines, American Society for Virology, International Association for Aquatic Animal Medicine. Clinical activities such as vaccination and diseases diagnosis in aquatic animals.
Research interests
Self-Assembling Nanovaccines and mRNA vaccines against viral pathogens.
Projects you're working on
Development of vaccines with commercial potential against WOAH-listed RNA viruses using a novel approach at the Ludwig-Maximilians-Universität Munich (Germany) in collaboration with Institute of Biotechnology and Biomedicine (Spain) and University of Salford (UK).
Discipline
Bacteriology Bio-manufacturing Bioinformatics Cellular biology Challenge model development Challenge study design Clinical trials – efficacy Clinical trials – safety Commercialisation Epidemiology Ethics Formulation technology Immunology – B-cells Immunology – T-cells Immunology – innate Molecular biology Pharmacovigilance Protein biology Safety evaluation Virology
Pathogen
BacteriaAeromonas BacteriaYersinia Viruses VirusesHerpesvirus VirusesInfectious pancreatic necrosis virus VirusesPiscine novirhabdovirus VirusesPoxviruses
Stage of vaccine development
Adjuvants Antigen discovery and immunogen design Clinical trials Commercialisation Correlates of protection – immunomonitoring Deployment Field trials Marketing Pre-clinical trials Vaccine delivery